Is Glaukos Corp Stock a Good Investment?
Glaukos Corp Investment Advice | GKOS |
- Examine Glaukos Corp's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Glaukos Corp's leadership team and their track record. Good management can help Glaukos Corp navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Glaukos Corp's business and its evolving consumer preferences.
- Compare Glaukos Corp's performance and market position to its competitors. Analyze how Glaukos Corp is positioned in terms of product offerings, innovation, and market share.
- Check if Glaukos Corp pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Glaukos Corp's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Glaukos Corp stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Glaukos Corp is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Insignificant | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Glaukos Corp Stock
Researching Glaukos Corp's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 97.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 1.64. Glaukos Corp recorded a loss per share of 2.93. The entity had not issued any dividends in recent years.
To determine if Glaukos Corp is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Glaukos Corp's research are outlined below:
| The company reported the previous year's revenue of 314.71 M. Net Loss for the year was (134.66 M) with profit before overhead, payroll, taxes, and interest of 276.06 M. | |
| Glaukos Corp currently holds about 391.19 M in cash with (57.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.22. | |
| Glaukos Corp has a frail financial position based on the latest SEC disclosures | |
| Over 97.0% of the company shares are owned by institutional investors | |
| Latest headline from gurufocus.com: FMR LLC Reduces Stake in Glaukos Corp A Strategic Reassessment |
Glaukos Corp Quarterly Gross Profit |
|
Glaukos Corp uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Glaukos Corp. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Glaukos Corp's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 28th of February 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 28th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Glaukos Corp's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Glaukos Corp's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2017-03-01 | 2016-12-31 | 0.0025 | 0.0036 | 0.0011 | 44 | ||
2017-08-02 | 2017-06-30 | 0.05 | 0.06 | 0.01 | 20 | ||
2018-02-28 | 2017-12-31 | 0.01 | 0.03 | 0.02 | 200 | ||
2021-11-04 | 2021-09-30 | -0.24 | -0.21 | 0.03 | 12 | ||
2021-05-06 | 2021-03-31 | -0.24 | -0.21 | 0.03 | 12 | ||
2018-08-02 | 2018-06-30 | -0.12 | -0.15 | -0.03 | 25 | ||
2018-05-09 | 2018-03-31 | -0.11 | -0.08 | 0.03 | 27 | ||
2016-11-10 | 2016-09-30 | -0.0027 | 0.03 | 0.0327 | 1211 |
Glaukos Corp Target Price Consensus
Glaukos target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Glaukos Corp's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 14 | Strong Buy |
Most Glaukos analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Glaukos stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Glaukos Corp, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationGlaukos Corp Target Price Projection
Glaukos Corp's current and average target prices are 153.20 and 155.25, respectively. The current price of Glaukos Corp is the price at which Glaukos Corp is currently trading. On the other hand, Glaukos Corp's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Glaukos Corp Market Quote on 17th of February 2025
Target Price
Analyst Consensus On Glaukos Corp Target Price
Glaukos Corp Analyst Ratings
Glaukos Corp's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Glaukos Corp stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Glaukos Corp's financials, market performance, and future outlook by experienced professionals. Glaukos Corp's historical ratings below, therefore, can serve as a valuable tool for investors.Know Glaukos Corp's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Glaukos Corp is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Glaukos Corp backward and forwards among themselves. Glaukos Corp's institutional investor refers to the entity that pools money to purchase Glaukos Corp's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Geode Capital Management, Llc | 2024-09-30 | 1.2 M | Fred Alger Management, Llc | 2024-09-30 | 1.1 M | Driehaus Capital Management Llc | 2024-09-30 | 861.6 K | William Blair Investment Management, Llc | 2024-12-31 | 809.6 K | Westfield Capital Management Company, L.p. | 2024-12-31 | 807.2 K | Jpmorgan Chase & Co | 2024-09-30 | 718.6 K | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 662.5 K | Gilder Gagnon Howe & Co Llc | 2024-09-30 | 658.6 K | Loomis, Sayles & Company Lp | 2024-12-31 | 654.1 K | Blackrock Inc | 2024-09-30 | 8.5 M | Fmr Inc | 2024-09-30 | 6.6 M |
Glaukos Corp's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 8.45 B.Market Cap |
|
Glaukos Corp's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.20) | (0.22) | |
| Return On Capital Employed | (0.17) | (0.18) | |
| Return On Assets | (0.13) | (0.14) | |
| Return On Equity | (0.34) | (0.32) |
Determining Glaukos Corp's profitability involves analyzing its financial statements and using various financial metrics to determine if Glaukos Corp is a good buy. For example, gross profit margin measures Glaukos Corp's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Glaukos Corp's profitability and make more informed investment decisions.
Glaukos Corp's Earnings Breakdown by Geography
Please note, the imprecision that can be found in Glaukos Corp's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Glaukos Corp. Check Glaukos Corp's Beneish M Score to see the likelihood of Glaukos Corp's management manipulating its earnings.
Evaluate Glaukos Corp's management efficiency
Glaukos Corp has return on total asset (ROA) of (0.0774) % which means that it has lost $0.0774 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.261) %, meaning that it created substantial loss on money invested by shareholders. Glaukos Corp's management efficiency ratios could be used to measure how well Glaukos Corp manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.22 in 2025. Return On Capital Employed is likely to drop to -0.18 in 2025. At this time, Glaukos Corp's Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 658 M in 2025, whereas Total Current Assets are likely to drop slightly above 241.4 M in 2025.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 8.58 | 4.50 | |
| Tangible Book Value Per Share | 2.09 | 1.35 | |
| Enterprise Value Over EBITDA | (57.98) | (60.88) | |
| Price Book Value Ratio | 7.50 | 7.88 | |
| Enterprise Value Multiple | (57.98) | (60.88) | |
| Price Fair Value | 7.50 | 7.88 | |
| Enterprise Value | 3.7 B | 2.4 B |
The management team at Glaukos Corp has a track record of steering the company towards sustained growth. Evaluating their strategies helps in understanding the stock's long-term potential.
Beta 1.047 |
Basic technical analysis of Glaukos Stock
As of the 17th of February 2025, Glaukos Corp retains the risk adjusted performance of 0.054, and Market Risk Adjusted Performance of (1.66). Glaukos Corp technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Glaukos Corp coefficient of variation, as well as the relationship between the treynor ratio and semi variance to decide if Glaukos Corp is priced fairly, providing market reflects its last-minute price of 153.2 per share. Given that Glaukos Corp has jensen alpha of 0.1287, we strongly advise you to confirm Glaukos Corp's regular market performance to make sure the company can sustain itself at a future point.Glaukos Corp's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Glaukos Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Glaukos Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Glaukos Corp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Glaukos Corp's Outstanding Corporate Bonds
Glaukos Corp issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Glaukos Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Glaukos bonds can be classified according to their maturity, which is the date when Glaukos Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US377320AA45 Corp BondUS377320AA45 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| GLAXOSMITHKLINE CAPITAL PLC Corp BondUS377373AH85 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View | |
| GLAXOSMITHKLINE CAP INC Corp BondUS377372AM97 | View | |
| GLAXOSMITHKLINE CAP INC Corp BondUS377372AN70 | View |
Understand Glaukos Corp's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Glaukos Corp's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.054 | |||
| Market Risk Adjusted Performance | (1.66) | |||
| Mean Deviation | 1.66 | |||
| Semi Deviation | 1.55 | |||
| Downside Deviation | 1.62 | |||
| Coefficient Of Variation | 1493.08 | |||
| Standard Deviation | 2.07 | |||
| Variance | 4.29 | |||
| Information Ratio | 0.0616 | |||
| Jensen Alpha | 0.1287 | |||
| Total Risk Alpha | 0.1254 | |||
| Sortino Ratio | 0.0789 | |||
| Treynor Ratio | (1.67) | |||
| Maximum Drawdown | 8.46 | |||
| Value At Risk | (2.98) | |||
| Potential Upside | 4.66 | |||
| Downside Variance | 2.61 | |||
| Semi Variance | 2.4 | |||
| Expected Short fall | (2.09) | |||
| Skewness | 0.7257 | |||
| Kurtosis | 0.1294 |
| Risk Adjusted Performance | 0.054 | |||
| Market Risk Adjusted Performance | (1.66) | |||
| Mean Deviation | 1.66 | |||
| Semi Deviation | 1.55 | |||
| Downside Deviation | 1.62 | |||
| Coefficient Of Variation | 1493.08 | |||
| Standard Deviation | 2.07 | |||
| Variance | 4.29 | |||
| Information Ratio | 0.0616 | |||
| Jensen Alpha | 0.1287 | |||
| Total Risk Alpha | 0.1254 | |||
| Sortino Ratio | 0.0789 | |||
| Treynor Ratio | (1.67) | |||
| Maximum Drawdown | 8.46 | |||
| Value At Risk | (2.98) | |||
| Potential Upside | 4.66 | |||
| Downside Variance | 2.61 | |||
| Semi Variance | 2.4 | |||
| Expected Short fall | (2.09) | |||
| Skewness | 0.7257 | |||
| Kurtosis | 0.1294 |
Consider Glaukos Corp's intraday indicators
Glaukos Corp intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Glaukos Corp stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Glaukos Corp Corporate Filings
| 12th of February 2025 Other Reports | ViewVerify | |
F5 | 24th of January 2025 The annual filing required by the Securities and Exchange Commission (SEC) from company insiders or beneficial owners | ViewVerify |
8K | 14th of January 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 8th of January 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Glaukos Stock media impact
Far too much social signal, news, headlines, and media speculation about Glaukos Corp that are available to investors today. That information is available publicly through Glaukos media outlets and privately through word of mouth or via Glaukos internal channels. However, regardless of the origin, that massive amount of Glaukos data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Glaukos Corp news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Glaukos Corp relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Glaukos Corp's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Glaukos Corp alpha.
Glaukos Corp Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Glaukos Corp can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Glaukos Corp Historical Investor Sentiment
Investor biases related to Glaukos Corp's public news can be used to forecast risks associated with an investment in Glaukos. The trend in average sentiment can be used to explain how an investor holding Glaukos can time the market purely based on public headlines and social activities around Glaukos Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Glaukos Corp's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Glaukos Corp and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Glaukos Corp news discussions. The higher the estimate score, the more favorable the investor's outlook on Glaukos Corp.
Glaukos Corp Maximum Pain Price Across April 17th 2025 Option Contracts
Glaukos Corp's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Glaukos Corp close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Glaukos Corp's options.
Glaukos Corp Corporate Directors
| Gilbert Kliman | Independent Director | Profile | |
| Mark Foley | Lead Independent Director | Profile | |
| Aimee Weisner | Independent Director | Profile | |
| David Hoffmeister | Independent Director | Profile |
Additional Tools for Glaukos Stock Analysis
When running Glaukos Corp's price analysis, check to measure Glaukos Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Glaukos Corp is operating at the current time. Most of Glaukos Corp's value examination focuses on studying past and present price action to predict the probability of Glaukos Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Glaukos Corp's price. Additionally, you may evaluate how the addition of Glaukos Corp to your portfolios can decrease your overall portfolio volatility.